22157.jpg
Worldwide Anticoagulants Industry to 2026 - Featuring Aspen Holdings, Bayer and Pfizer Among Others
July 07, 2021 04:33 ET | Research and Markets
Dublin, July 07, 2021 (GLOBE NEWSWIRE) -- The "Global Anticoagulants Market (2021-2026) by Drug Class, Route of Administration, Geography and the Impact of COVID-19 with Ansoff Analysis" report has...
gmi logo.jpg
Anticoagulants Market revenue to cross USD 51.9 Bn by 2027: Global Market Insights Inc.
March 08, 2021 04:00 ET | Global Market Insights, Inc
Selbyville, Delaware, March 08, 2021 (GLOBE NEWSWIRE) -- According to latest report “Anticoagulants Market by Drug Class (Factor Xa Inhibitors, Heparin, Warfarin, Direct Thrombin Inhibitors),...
FCL.png
Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments
January 06, 2021 13:14 ET | Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be monitoring the safety and efficacy of vaccines and...
22157.jpg
Alphanate: A Sterile, Lyophilized Concentrate of FVIII (AHF) and Von Willebrand Factor - Global Drug Insight and Market Forecast 2017-2030
December 30, 2020 09:03 ET | Research and Markets
Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "Alphanate - Drug Insight and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. Alphanate - Drug Insight and Market...
FCL.png
Franciosi Consulting Assessing New Potential Treatments for Asthma and COPD
December 29, 2020 17:20 ET | Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be assessing the use of glycosaminoglycans (GAGs) for the...
FCL.png
Lui Franciosi Reviewing the Use of Sugar-Based Molecules as Potential Treatments for COVID-19
December 29, 2020 17:04 ET | Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be reviewing the pharmacological feasibility of using specific...
22157.jpg
Global Blood Collection Market (2020 to 2025) - Increasing Demand for Apheresis Presents Opportunities
September 22, 2020 07:08 ET | Research and Markets
Dublin, Sept. 22, 2020 (GLOBE NEWSWIRE) -- The "Blood Collection Market by Product (Tubes (Plasma (EDTA, Heparin, Glucose), Serum), Blood Bags, Monitors, Needles), Method (Manual, Automated),...
22157.jpg
Global and United States Anticoagulants Market Size & Forecast Report 2020-2024 with Impact Analysis of COVID-19
September 14, 2020 07:38 ET | Research and Markets
Dublin, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The "Global Anticoagulants Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024 Edition)" report has been added to...
BBRAUN SE_GREEN (1).jpg
B. Braun launches the First FDA-Approved Heparin Sodium Prefilled Syringe with attached safety needle
April 24, 2019 15:14 ET | B. Braun Medical Inc.--US
BETHLEHEM, Pa., April 24, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. announced today the launch of its Heparin Sodium Injection, USP - the first Heparin 5,000 USP Unit / 0.5 mL prefilled syringe...
Akers Bio logo
Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update
October 08, 2018 02:00 ET | Akers Biosciences Inc
THOROFARE, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...